Riskpilot← Back to searchSign inGet full accessDYRLEGENE KLINIKK AS
ASActiveOrg 920248527Stormyrveien 25, 8008 BodøVeterinary activities · NACE 7500Est. 201828 employees
Revenue 2024
NOK 21,2M
+7% vs 2023
EBITDA margin
3.4%
+216% vs 2023
Equity ratio
16.4%
Financial strength
Net profit 2024
NOK 394K
+988% vs 2023
| Revenue | NOK 21,2M | +7% |
| EBITDA | NOK 714K | +216% |
| Net profit | NOK 394K | +988% |
| Total assets | NOK 5M | +35% |
| Equity | NOK 818K | -11% |
| Employees | 28 | — |
Legal name
DYRLEGENE KLINIKK AS
Org number
920248527
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
17. januar 2018
Share capital
NOK 30 000
Employees
28 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Dyreklinikk, samt alt som naturlig hører under dette.
Address
Stormyrveien 25, 8008 Bodø
Phone
+4775561800
Email
post@dyrlegenebodo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 889 | 17 290 | 18 811 | 19 802 | 21 208 |
| Staff expenses | −8 569 | −10 155 | −10 618 | −11 893 | −12 816 |
| EBITDA | 765 | 1 170 | 1 383 | 226 | 714 |
| Depreciation & amort. | −158 | −182 | −175 | −199 | −194 |
| EBIT | 607 | 988 | 1 208 | 27 | 521 |
| Net financials | −23 | −15 | −19 | −7 | −13 |
| Profit before tax | 584 | 973 | 1 189 | 21 | 508 |
| Tax | 134 | 220 | 266 | 65 | 113 |
| Net profit | 450 | 753 | 923 | −44 | 394 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 215 | 4 149 | 4 492 | 3 693 | 4 996 |
| Equity | 1 491 | 644 | 1 568 | 923 | 818 |
| Long-term debt | 257 | 261 | 170 | 192 | 199 |
| Short-term debt | 2 467 | 3 244 | 2 754 | 2 577 | 3 979 |
| Total debt | 2 723 | 3 505 | 2 924 | 2 769 | 4 178 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
16.4%
This company
38.2%
Market median
-57% vs market
20202024
Return on equity
48.2%
This company
18.4%
Market median
+162% vs market
20202024
Net profit margin
1.9%
This company
8.1%
Market median
-77% vs market
20202024
Asset turnover
4.25×
This company
1.12×
Market median
+279% vs market
20202024
Debt / equity
5.11×
This company
0.62×
Market median
-724% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KB Chief Executive Officer | Chief Executive Officer | 2025 |
LH Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 80% | 80% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DYRLEGENE KLINIKK AS 
DYRLEGENE-NÆR DEG ASBoard members of DYRLEGENE KLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karina Berntsen Arhaug | Chief Executive Officer | 0 companies |
| Liv Hege Jenssen | Chief Executive Officer | 0 companies |
| Eivind Undrum Jacobsen | Chairman | 0 companies |
| Linda Bakken Bøe | Board of Directors | 0 companies |
| Bjørn Bredal | Board of Directors | 0 companies |